APP and Alzheimer disease: Combining EGCG and a therapeutic gene in a multifunctional nanocarrier significantly increased spatial learning and memory capacities in APP/PS1 and wild-type mice, suggesting that co-delivering these molecules may be highly effective in AD treatment [47].